Sechenov School
Home › Pharmacology › General Anesthetics

General Anesthetics

Anaesthetica generalia

For medical students2 min readUpdated 2026-10-10

General anesthetics are a group of medications that induce reversible depression of the central nervous system to provide surgical anesthesia. Their action is based on complex interactions with neuronal receptors and alterations in the pharmacokinetic parameters of gas exchange.

Main targetsGABA, glycine, and glutamate NMDA receptors.
SpeedDetermined by the blood/gas partition coefficient.
Rapid onsetXenon, sevoflurane, and nitrous oxide.
NeurotransmittersDecreased release of dopamine, serotonin, and norepinephrine.

Molecular and Neurochemical Mechanisms

The action of general anesthetics is realized at multiple levels of the central nervous system. Their effect is based on the ability to modulate ion channels and receptors, shifting the balance toward the inhibition of nerve impulses.

Key mechanisms of receptor interaction:

Interestingly, specific binding sites have been discovered directly on these receptor complexes for most drugs in this group.

In addition, inhalational anesthetic agents directly affect synaptic transmission, significantly reducing the release of key neurotransmitters in the CNS. Under their influence, the release of acetylcholine, dopamine, serotonin, and norepinephrine decreases, further depressing brain activity.

Pharmacokinetics: Onset of Action

For inhalational agents, the blood/gas partition coefficient is a critical pharmacokinetic parameter. This metric dictates how quickly a patient will go under anesthesia and how rapidly they will wake up after the administration is stopped.

The dependence mechanism is directly related to the physical solubility of the anesthetic in the blood. If solubility is high, the drug easily and in large amounts passes from lung alveoli into the bloodstream. Consequently, it begins to "accumulate" in the liquid part of the blood, and significant time is required to build the necessary partial pressure for the substance to cross into brain tissue.

Characteristics of Modern Agents

The clinical picture of modern inhalational agents shows variability. Unlike older drugs, newer anesthetics exhibit a significantly milder excitation stage, making induction smoother and safer.

At the same time, the depth of achieved analgesia (pain relief) can vary greatly depending on the chosen drug, which requires careful monitoring of the blood/gas coefficient and knowledge of the specific substance's receptor profile.

Mnemonic

The WORSE an anesthetic dissolves in blood, the FASTER it enters the brain (rapid induction and rapid recovery).

Frequently asked questions

What stages are distinguished in the clinical picture of classic ether anesthesia?

The clinical picture of classic ether anesthesia is divided into four sequential stages.

  • Stage I — Analgesia (consciousness preserved, eyelids closed).
  • Stage II — Excitation (eyelids tightly squeezed, bright red skin color).
  • Stage III — Surgical (tolerant). Divided into 4 depth levels: superficial, light, deep, and ultra-deep anesthesia. Characterized by the disappearance of excitation signs, normalized breathing, decreased muscle tone, and complete loss of consciousness.
  • Stage IV — Awakening (eyelids alternatingly half-open or closed).
Which drugs belong to the group of non-inhalational general anesthetics?

The group of non-inhalational (intravenous and rectal) general anesthetics includes:

  • Hexobarbital — medium duration of action.
  • Thiopental sodium — medium-duration barbiturate with rapid onset.
  • Propanidid — short-acting agent.
  • Propofol — short-acting anesthetic.
  • Etomidate — short-acting agent.
  • Ketamine — short-acting agent causing dissociative anesthesia.
  • Sodium oxybate — long-acting agent.

Also includes epontol, baytinal, and viadril.

What specific side effects are characteristic of halothane?

Halothane is characterized by the following specific side effects:

  • Myocardial sensitization — increased sensitivity of the heart to catecholamines, raising the risk of severe arrhythmias when epinephrine is administered.
  • Malignant hyperthermia — a life-threatening condition with a sharp temperature spike up to 42–43 °C and skeletal muscle spasm, occurring when halothane is combined with succinylcholine.
  • Hypotension — decreased blood pressure due to vasomotor center depression, ganglion-blocking, and direct myotropic action.
  • Bradycardia — slowed heart rate due to vagal center stimulation.
Which non-inhalational anesthetic causes dissociative anesthesia via NMDA receptor blockade?

Ketamine causes dissociative anesthesia via NMDA receptor blockade. This drug is a phencyclidine derivative and acts as a non-competitive NMDA receptor antagonist, eliminating the excitatory influence of glutamate on CNS structures.

  • Dissociative anesthesia — a state of functional disconnection where certain brain structures are depressed while others remain active.

Spontaneous breathing, muscle tone, and reflexes are preserved, consciousness is only partially lost, but pronounced analgesia and amnesia are achieved. The surgical anesthesia stage is not reached.

Which excitatory receptors are blocked by general anesthetics?

They primarily suppress the activity of glutamate receptors, specifically NMDA receptors.

How does blood solubility affect recovery speed?

Drugs with low blood solubility (a low blood/gas partition coefficient) provide the fastest recovery from anesthesia.

Which inhibitory neurotransmitters are affected by anesthesia?

Anesthetics enhance receptor sensitivity to GABA in the brain and glycine in the spinal cord.

Go deeper

More topics in Pharmacology

Physiological Mechanisms of Blood Pressure RegulationPhysiology of Myocardial ContractionBacterial Protein Synthesis: Antibiotic TargetsAntiherpetic Drugs: Pharmacology and Mechanism of ActionAntimalarial DrugsVitaminsAnalepticsCardiotonic Agents: Pharmacology and Mechanism of ActionUric Acid-Lowering DrugsAntiseptics and Disinfectants: Additional GroupsAntineoplastic AgentsCocainePharmacology →